Alzamend Neuro, Inc. Profile Avatar - Palmy Investing

Alzamend Neuro, Inc.

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, wh…

Biotechnology
US, Atlanta [HQ]

Earnings Call Transcripts

Could not find a transcript
End of ALZN's Analysis
CIK: 1677077 CUSIP: 02262M308 ISIN: US02262M4078 LEI: - UEI: -
Secondary Listings
ALZN has no secondary listings inside our databases.